obesity

Calorie Labelling Efficacy Varies by Socioeconomic Status

Mandatory calorie menu labelling in England shows varied impact, with greater efficacy in higher socioeconomic groups and limited effect in lower groups.

Protein and Creatine Supplement Use Expands Beyond Niche Demographics

Once confined to athletes, protein and creatine supplements are now widely used across diverse populations, necessitating clinician awareness.

Weekly survodutide reduces obesity and metabolic liver disease

Weekly survodutide demonstrates dual efficacy in reducing body weight and improving markers of metabolic dysfunction-associated steatotic liver disease (MASLD).

ACP Issues Guidance on Medications for Obesity, Overweight

The American College of Physicians (ACP) has released new guidance on pharmacologic treatments for obesity and overweight, focusing on efficacy and safety.

Exercise Declined in Patients with Obesity After Starting a GLP-1

Patients with obesity showed reduced physical activity after initiating GLP-1 receptor agonists, according to a recent analysis.

GLP-1 Weight Regain: Emerging Strategies to Sustain Loss

Strategies are emerging to mitigate weight regain post-GLP-1 receptor agonist discontinuation, focusing on sustained pharmacological intervention.

Retatrutide Shows 24.2% Weight Reduction in Phase II Trial

A Phase II trial of retatrutide demonstrated substantial weight loss and improvements in cardiometabolic markers in adults with obesity.

Obesity Care: Tailored Treatment Strategies Highlighted at endo 2026

Personalised treatment approaches for obesity, moving beyond a 'one-size-fits-all' model, were a key focus at endo 2026.

Peer Insights on Once-Daily Weight Management Therapy at endo 2026

Endocrinology specialists discussed the clinical utility of a once-daily treatment for weight management in appropriate adult patients.